Early-Stop trial tests malaria drug for COVID-19
NCT ID NCT04345692
Summary
This study aimed to see if adding the drug hydroxychloroquine to standard hospital care helped adults with COVID-19 get better faster. It compared patients who received the drug for five days to those who received only usual care. The trial was stopped early after enrolling only 17 of a planned 350 patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Queen's Medical Center
Honolulu, Hawaii, 96813, United States
Conditions
Explore the condition pages connected to this study.